Heart Disease Clinical Trials in Nashville

Showing 21-40 of 390 trials

INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery

NCT06965504

The study will evaluate if Impella 5.5® support in heart failure reduced ejection fraction (HFrEF) patients presenting with decompensated heart failure (HF) and cardiogenic shock will facilitate the initiation and optimization of guideline directed medical therapy (GDMT) during the hospital stay and post-discharge.

Heart FailureCardiogenic ShockReduced Ejection Fraction Heart Failure

Abiomed Inc.60 participantsStarted Apr 2026

Tampa, Florida, United States • Minneapolis, Minnesota, United States • New Brunswick, New Jersey, United States +2 more locations

RECRUITING< 1 mile

Product Surveillance Registry

NCT01524276

The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by streamlining the clinical surveillance process and facilitating leading edge performance assessment via the least burdensome approach.

Cardiac Rhythm DisordersUrological DisordersNeurological Disorders+13 more

Medtronic100,000 participantsStarted Jan 2012

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Chandler, Arizona, United States +386 more locations

INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery

Product Surveillance Registry

Heart Disease Trials in Other Cities

A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia

Aventus Thrombectomy System Pulmonary Embolism Clinical Study

Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD

A Proof of Concept and Dose-finding Study of XXB750 in Patients With Heart Failure

Shockwave C2+ 2Hz Coronary IVL Catheter in Calcified Coronary Arteries (Disrupt CAD DUO)

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

PIONEER III Trial to Assess Safety and Efficacy of the BuMA Supreme™ Drug Coated Coronary Stent in Patients With Coronary Disease

A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma

Lumason® Infusion vs. Bolus Administrations

EXCOR Active Driving System for the EXCOR Pediatric VAD IDE Study

Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study

His-Bundle Corrective Pacing in Heart Failure

Fast Induced Remodeling in Heart Failure With Preserved Ejection Fraction

A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)

RAdiolabeled Perfusion to Identify Coronary Artery Disease Using WAter To Evaluate Responses of Myocardial FLOW (RAPID-WATER-FLOW)

Conduction System Pacing International Registry (CONSPIRE)

A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)

Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System

Other Conditions in Nashville